Cargando…
Resolution of cryptogenic new onset refractory status epilepticus with tocilizumab
New onset refractory status epilepticus (NORSE) was defined by the International League Against Epilepsy as occurring in patients presenting without a prior diagnosis of epilepsy or other neurological disease, with seizures that persist beyond 24 h. There is still a need to develop new treatment str...
Autores principales: | Donnelly, Jonathan P., Kasatwar, Nidhi, Hafeez, Shaheryar, Seifi, Ali, Gilbert, Andrea, Barthol, Colleen, Small, Clay, Ákos Szabó, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972955/ https://www.ncbi.nlm.nih.gov/pubmed/33748736 http://dx.doi.org/10.1016/j.ebr.2021.100431 |
Ejemplares similares
-
Reversible Brain Atrophy in Cryptogenic New-onset Refractory Status Epilepticus
por: Watanabe, Tomoaki, et al.
Publicado: (2022) -
Hereditary Coproporphyria Mimicking Guillain-Barré Syndrome After COVID-19 Infection
por: Upchurch, Margaret, et al.
Publicado: (2022) -
Adult-onset Rasmussen's Syndrome with associated cortical dysplasia
por: Szabó, C. Ákos, et al.
Publicado: (2018) -
Neuromodulation in new-onset refractory status epilepticus
por: Stavropoulos, Ioannis, et al.
Publicado: (2023) -
Idiopathic Hypoparathyroidism Presenting As New Onset Refractory Status Epilepticus
por: Gomathy, Saranya B., et al.
Publicado: (2021)